KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Bionano Genomics (BNGO) Assets Average (2018 - 2025)

Historic Assets Average for Bionano Genomics (BNGO) over the last 8 years, with Q3 2025 value amounting to $77.5 million.

  • Bionano Genomics' Assets Average fell 2844.79% to $77.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $77.5 million, marking a year-over-year decrease of 2844.79%. This contributed to the annual value of $145.5 million for FY2024, which is 4422.87% down from last year.
  • Per Bionano Genomics' latest filing, its Assets Average stood at $77.5 million for Q3 2025, which was down 2844.79% from $77.2 million recorded in Q2 2025.
  • In the past 5 years, Bionano Genomics' Assets Average registered a high of $370.8 million during Q2 2021, and its lowest value of $77.2 million during Q2 2025.
  • For the 5-year period, Bionano Genomics' Assets Average averaged around $232.4 million, with its median value being $226.6 million (2023).
  • As far as peak fluctuations go, Bionano Genomics' Assets Average skyrocketed by 150167.15% in 2021, and later plummeted by 5861.0% in 2024.
  • Quarter analysis of 5 years shows Bionano Genomics' Assets Average stood at $368.4 million in 2021, then decreased by 14.33% to $315.6 million in 2022, then tumbled by 37.21% to $198.2 million in 2023, then tumbled by 58.61% to $82.0 million in 2024, then fell by 5.46% to $77.5 million in 2025.
  • Its Assets Average stands at $77.5 million for Q3 2025, versus $77.2 million for Q2 2025 and $77.5 million for Q1 2025.